Skip to main content
Erschienen in: International Journal of Legal Medicine 2/2020

29.03.2019 | Original Article

Increased inducible nitric oxide synthase (iNOS) expression in human myocardial infarction

verfasst von: Verena Wilmes, Stefanie Scheiper, Winta Roehr, Constanze Niess, Stefan Kippenberger, Katja Steinhorst, Marcel A. Verhoff, Silke Kauferstein

Erschienen in: International Journal of Legal Medicine | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Increased inducible nitric oxide synthase (iNOS) expression has been reported in heart failure, cardiomyopathies, and arteriosclerosis. iNOS is expressed in the heart upon inflammatory stimuli and produces excessive amounts of nitric oxide (NO). The overproduction of NO is cytotoxic and involved in cardiovascular diseases. Furthermore, iNOS produces superoxide anion which proceeds with NO to the harmful oxidant peroxynitrite, causing oxidative stress in the heart. The aim of the study was to gain new insights into the role of iNOS in human myocardial infarction (MI) and its contribution to oxidative stress in the heart. Furthermore, we investigated the unaffected myocardium of the infarction hearts, to study if iNOS expression is increased, probably as an indicator for oxidative stress. Our results show a significant increase (p = 0.013) of the iNOS expression in the affected regions of MI hearts (n = 9) in comparison with healthy control hearts (n = 4). In the unaffected regions of MI hearts, an increase in the iNOS expression in some samples was found as well. Our study demonstrated the direct detection of iNOS mRNA in human myocardial tissue. The balance between beneficial and deleterious effects of iNOS may be particularly influenced by the presence or absence of concurrent oxidative stress.
Literatur
1.
Zurück zum Zitat Lind M, Hayes A, Caprnda M, Petrovic D, Rodrigo L, Kruzliak P, Zulli A (2017) Inducible nitric oxide synthase: good or bad? Biomed Pharmacother 93:370–375CrossRef Lind M, Hayes A, Caprnda M, Petrovic D, Rodrigo L, Kruzliak P, Zulli A (2017) Inducible nitric oxide synthase: good or bad? Biomed Pharmacother 93:370–375CrossRef
2.
Zurück zum Zitat Caimi G, Montana M, Calandrino V, Caruso M, Carollo C, Catania A, Lo Presti R (2008) Nitric oxide metabolites (nitrite and nitrate) in young patients with recent acute myocardial infarction. Clin Hemorheol Microcirc 40(2):157–163CrossRef Caimi G, Montana M, Calandrino V, Caruso M, Carollo C, Catania A, Lo Presti R (2008) Nitric oxide metabolites (nitrite and nitrate) in young patients with recent acute myocardial infarction. Clin Hemorheol Microcirc 40(2):157–163CrossRef
3.
Zurück zum Zitat Searles CD (2002) The nitric oxide pathway and oxidative stress in heart failure. Congest Heart Fail 8(3):142–155CrossRef Searles CD (2002) The nitric oxide pathway and oxidative stress in heart failure. Congest Heart Fail 8(3):142–155CrossRef
4.
Zurück zum Zitat Melillo G (1995) A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med 182(6):1683–1693CrossRef Melillo G (1995) A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med 182(6):1683–1693CrossRef
5.
Zurück zum Zitat Soskić SS, Dobutović BD, Sudar EM, Obradović MM, Nikolić DM, Djordjevic JD, Radak DJ, Mikhailidis DP, Isenović ER (2011) Regulation of inducible nitric oxide synthase (iNOS) and its potential role in insulin resistance, diabetes and heart failure. Open Cardiovasc Med J 5:153–163CrossRef Soskić SS, Dobutović BD, Sudar EM, Obradović MM, Nikolić DM, Djordjevic JD, Radak DJ, Mikhailidis DP, Isenović ER (2011) Regulation of inducible nitric oxide synthase (iNOS) and its potential role in insulin resistance, diabetes and heart failure. Open Cardiovasc Med J 5:153–163CrossRef
6.
Zurück zum Zitat Brady AJ, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE (1993) Nitric oxide attenuates cardiac myocyte contraction. Am J Phys 265(1 Pt 2):H176–H182 Brady AJ, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE (1993) Nitric oxide attenuates cardiac myocyte contraction. Am J Phys 265(1 Pt 2):H176–H182
7.
Zurück zum Zitat Li H-M, Liu L, Mei X, Chen H, Liu Z, Zhao X (2014) Overexpression of inducible nitric oxide synthase impairs the survival of bone marrow stem cells transplanted into rat infarcted myocardium. Life Sci 106(1–2):50–57CrossRef Li H-M, Liu L, Mei X, Chen H, Liu Z, Zhao X (2014) Overexpression of inducible nitric oxide synthase impairs the survival of bone marrow stem cells transplanted into rat infarcted myocardium. Life Sci 106(1–2):50–57CrossRef
8.
Zurück zum Zitat Feng Q, Lu X, Jones DL, Shen J, Arnold JM (2001) Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation 104(6):700–704CrossRef Feng Q, Lu X, Jones DL, Shen J, Arnold JM (2001) Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation 104(6):700–704CrossRef
9.
Zurück zum Zitat Zhang P, Xu X, Hu X, van Deel ED, Zhu G, Chen Y (2007) Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure. Circ Res 100(7):1089–1098CrossRef Zhang P, Xu X, Hu X, van Deel ED, Zhu G, Chen Y (2007) Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure. Circ Res 100(7):1089–1098CrossRef
10.
Zurück zum Zitat Costa S, Reina-Couto M, Albino-Teixeira A, Sousa T (2016) Statins and oxidative stress in chronic heart failure. Rev Port Cardiol (Engl Ed) 35(1):41–57CrossRef Costa S, Reina-Couto M, Albino-Teixeira A, Sousa T (2016) Statins and oxidative stress in chronic heart failure. Rev Port Cardiol (Engl Ed) 35(1):41–57CrossRef
11.
Zurück zum Zitat Bailey A, Pope TW, Moore SA, Campbell CL (2007) The tragedy of TRIUMPH for nitric oxide synthesis inhibition in cardiogenic shock. Am J Cardiovasc Drugs 7(5):337–345CrossRef Bailey A, Pope TW, Moore SA, Campbell CL (2007) The tragedy of TRIUMPH for nitric oxide synthesis inhibition in cardiogenic shock. Am J Cardiovasc Drugs 7(5):337–345CrossRef
12.
Zurück zum Zitat Huang H, Koelle P, Fendler M, Schröttle A, Czihal M, Hoffmann U, Conrad M, Kuhlencordt PJ (2014) Induction of inducible nitric oxide synthase (iNOS) expression by oxLDL inhibits macrophage derived foam cell migration. Atherosclerosis 235(1):213–222CrossRef Huang H, Koelle P, Fendler M, Schröttle A, Czihal M, Hoffmann U, Conrad M, Kuhlencordt PJ (2014) Induction of inducible nitric oxide synthase (iNOS) expression by oxLDL inhibits macrophage derived foam cell migration. Atherosclerosis 235(1):213–222CrossRef
13.
Zurück zum Zitat Gori T, Münzel T (2011) Oxidative stress and endothelial dysfunction: therapeutic implications. Ann Med 43(4):259–272CrossRef Gori T, Münzel T (2011) Oxidative stress and endothelial dysfunction: therapeutic implications. Ann Med 43(4):259–272CrossRef
14.
Zurück zum Zitat Jones DP (2008) Radical-free biology of oxidative stress. Am J Physiol Cell Physiol 295(4):C849–C868CrossRef Jones DP (2008) Radical-free biology of oxidative stress. Am J Physiol Cell Physiol 295(4):C849–C868CrossRef
15.
Zurück zum Zitat Münzel T, Gori T, Bruno RM, Taddei S (2010) Is oxidative stress a therapeutic target in cardiovascular disease? Eur Heart J 31(22):2741–2748CrossRef Münzel T, Gori T, Bruno RM, Taddei S (2010) Is oxidative stress a therapeutic target in cardiovascular disease? Eur Heart J 31(22):2741–2748CrossRef
16.
Zurück zum Zitat Gosslau A, Rensing L (2002) Oxidativer Stress, altersabhängige Zellschädigungen und antioxidative Mechanismen. Z Gerontol Geriatr 35(2):139–150CrossRef Gosslau A, Rensing L (2002) Oxidativer Stress, altersabhängige Zellschädigungen und antioxidative Mechanismen. Z Gerontol Geriatr 35(2):139–150CrossRef
17.
Zurück zum Zitat Ho E, Karimi Galougahi K, Liu C-C, Bhindi R, Figtree GA (2013) Biological markers of oxidative stress: applications to cardiovascular research and practice. Redox Biol 1:483–491CrossRef Ho E, Karimi Galougahi K, Liu C-C, Bhindi R, Figtree GA (2013) Biological markers of oxidative stress: applications to cardiovascular research and practice. Redox Biol 1:483–491CrossRef
18.
Zurück zum Zitat Paslawska U, Kiczak L, Bania J, Paslawski R, Janiszewski A, Dzięgiel P, Zacharski M, Tomaszek A, Michlik K (2016) Inducible NO synthase is constitutively expressed in porcine myocardium and its level decreases along with tachycardia-induced heart failure. Cardiovasc Pathol 25(1):3–11CrossRef Paslawska U, Kiczak L, Bania J, Paslawski R, Janiszewski A, Dzięgiel P, Zacharski M, Tomaszek A, Michlik K (2016) Inducible NO synthase is constitutively expressed in porcine myocardium and its level decreases along with tachycardia-induced heart failure. Cardiovasc Pathol 25(1):3–11CrossRef
19.
Zurück zum Zitat Kunsch C, Medford RM (1999) Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 85(8):753–766CrossRef Kunsch C, Medford RM (1999) Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 85(8):753–766CrossRef
20.
Zurück zum Zitat Ghosh S, Karin M (2002) Missing pieces in the NF-kappaB puzzle. Cell 109(109 Suppl):S81–S96CrossRef Ghosh S, Karin M (2002) Missing pieces in the NF-kappaB puzzle. Cell 109(109 Suppl):S81–S96CrossRef
21.
Zurück zum Zitat Giordano FJ (2005) Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 115(3):500–508CrossRef Giordano FJ (2005) Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 115(3):500–508CrossRef
22.
Zurück zum Zitat Prabhu SD (2004) Nitric oxide protects against pathological ventricular remodeling: reconsideration of the role of NO in the failing heart. Circ Res 94(9):1155–1157CrossRef Prabhu SD (2004) Nitric oxide protects against pathological ventricular remodeling: reconsideration of the role of NO in the failing heart. Circ Res 94(9):1155–1157CrossRef
23.
Zurück zum Zitat Pacher P, Beckman JS, Liaudet L (2007) Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87(1):315–424CrossRef Pacher P, Beckman JS, Liaudet L (2007) Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87(1):315–424CrossRef
24.
Zurück zum Zitat Koppelkamm A, Vennemann B, Fracasso T, Lutz-Bonengel S, Schmidt U, Heinrich M (2010) Validation of adequate endogenous reference genes for the normalisation of qPCR gene expression data in human post mortem tissue. Int J Legal Med 124(5):371–380CrossRef Koppelkamm A, Vennemann B, Fracasso T, Lutz-Bonengel S, Schmidt U, Heinrich M (2010) Validation of adequate endogenous reference genes for the normalisation of qPCR gene expression data in human post mortem tissue. Int J Legal Med 124(5):371–380CrossRef
25.
Zurück zum Zitat Pilbrow AP, Ellmers LJ, Black MA, Moravec CS, Sweet WE, Troughton RW, Richards AM, Frampton CM, Cameron VA (2008) Genomic selection of reference genes for real-time PCR in human myocardium. BMC Med Genet 1:64 Pilbrow AP, Ellmers LJ, Black MA, Moravec CS, Sweet WE, Troughton RW, Richards AM, Frampton CM, Cameron VA (2008) Genomic selection of reference genes for real-time PCR in human myocardium. BMC Med Genet 1:64
26.
Zurück zum Zitat Hellemans J, Mortier G, de PA, Speleman F, Vandesompele J (2007) qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8(2):R19CrossRef Hellemans J, Mortier G, de PA, Speleman F, Vandesompele J (2007) qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8(2):R19CrossRef
27.
Zurück zum Zitat Koppelkamm A, Vennemann B, Lutz-Bonengel S, Fracasso T, Vennemann M (2011) RNA integrity in post-mortem samples: influencing parameters and implications on RT-qPCR assays. Int J Legal Med 125(4):573–580CrossRef Koppelkamm A, Vennemann B, Lutz-Bonengel S, Fracasso T, Vennemann M (2011) RNA integrity in post-mortem samples: influencing parameters and implications on RT-qPCR assays. Int J Legal Med 125(4):573–580CrossRef
28.
Zurück zum Zitat Pierini D, Bryan NS (2015) Nitric oxide availability as a marker of oxidative stress. Methods Mol Biol 1208:63–71CrossRef Pierini D, Bryan NS (2015) Nitric oxide availability as a marker of oxidative stress. Methods Mol Biol 1208:63–71CrossRef
29.
Zurück zum Zitat Tokmak A, Yıldırım G, Sarıkaya E, Çınar M, Boğdaycıoğlu N, Yılmaz FM, Yılmaz N (2015) Increased oxidative stress markers may be a promising indicator of risk for primary ovarian insufficiency: a cross-sectional case control study. Rev Bras Ginecol Obstet 37(9):411–416PubMed Tokmak A, Yıldırım G, Sarıkaya E, Çınar M, Boğdaycıoğlu N, Yılmaz FM, Yılmaz N (2015) Increased oxidative stress markers may be a promising indicator of risk for primary ovarian insufficiency: a cross-sectional case control study. Rev Bras Ginecol Obstet 37(9):411–416PubMed
30.
Zurück zum Zitat Menchén LA, Colón AL, Moro MA, Leza JC, Lizasoain I, Menchén P, Alvarez E, Lorenzo P (2001) N-(3-(aminomethyl)benzyl)acetamidine, an inducible nitric oxide synthase inhibitor, decreases colonic inflammation induced by trinitrobenzene sulphonic acid in rats. Life Sci 69(4):479–491CrossRef Menchén LA, Colón AL, Moro MA, Leza JC, Lizasoain I, Menchén P, Alvarez E, Lorenzo P (2001) N-(3-(aminomethyl)benzyl)acetamidine, an inducible nitric oxide synthase inhibitor, decreases colonic inflammation induced by trinitrobenzene sulphonic acid in rats. Life Sci 69(4):479–491CrossRef
Metadaten
Titel
Increased inducible nitric oxide synthase (iNOS) expression in human myocardial infarction
verfasst von
Verena Wilmes
Stefanie Scheiper
Winta Roehr
Constanze Niess
Stefan Kippenberger
Katja Steinhorst
Marcel A. Verhoff
Silke Kauferstein
Publikationsdatum
29.03.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
International Journal of Legal Medicine / Ausgabe 2/2020
Print ISSN: 0937-9827
Elektronische ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-019-02051-y

Weitere Artikel der Ausgabe 2/2020

International Journal of Legal Medicine 2/2020 Zur Ausgabe

Neu im Fachgebiet Rechtsmedizin